STOCK TITAN

Nutex Health (NUTX) director Kelvin Spears issued 2,519 shares in private merger-related transaction

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Nutex Health Inc. reported that director Kelvin Spears received 2,519 shares of common stock in a private, non-market transaction. The issuance relates to one-time obligations tied to his pro-rata share of an under-construction hospital transferred under a 2021 merger agreement, bringing his direct holdings to 34,656 shares.

Positive

  • None.

Negative

  • None.
Insider Spears Kelvin
Role null
Type Security Shares Price Value
Other Common Stock 2,519 $0.00 --
Holdings After Transaction: Common Stock — 34,656 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares issued 2,519 shares Common Stock issued in private transaction
Price per share $0.0000 Reported transaction price per share
Post-transaction holdings 34,656 shares Direct ownership after transaction
Restructuring shares 2,519 shares Classified as restructuring under code J
private transaction financial
"Represents the issuance in private transaction of 2,519 shares of common stock"
A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.
Agreement and Plan of Merger regulatory
"previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021"
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
Schedule 14A regulatory
"described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission"
Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.
Form 10-K regulatory
"and the Form 10-K filed with the SEC on March 5, 2026"
A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.
Other acquisition or disposition financial
"transaction_code_description: Other acquisition or disposition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Spears Kelvin

(Last)(First)(Middle)
1776 YORKTOWN STREET SUITE 700
C/O NUTEX HEALTH INC.

(Street)
HOUSTON TEXAS 33446

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/04/2026J2,519A$0(1)34,656D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the issuance in private transaction of 2,519 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of one under construction hospital previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.
/s/ Kelvin Spears06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Nutex Health (NUTX) director Kelvin Spears report?

Director Kelvin Spears reported receiving 2,519 Nutex Health common shares. The shares were issued in a private, non-market transaction linked to one-time obligations from a prior hospital transfer under a 2021 merger agreement, increasing his direct holdings to 34,656 shares.

Was Kelvin Spears’ Nutex Health (NUTX) Form 4 a market buy or sell?

The Form 4 does not show a market buy or sell. It records an “other” transaction where 2,519 shares were issued in a private deal to satisfy one-time obligations related to an under-construction hospital previously transferred under a 2021 merger agreement.

How many Nutex Health (NUTX) shares does Kelvin Spears own after this Form 4?

After the reported transaction, Kelvin Spears beneficially holds 34,656 Nutex Health common shares directly. This reflects the addition of 2,519 shares issued in a private transaction connected to contractual obligations from a prior hospital transfer under a 2021 merger agreement.

What does transaction code J mean in the Nutex Health (NUTX) Form 4?

Transaction code J on Kelvin Spears’ Form 4 indicates an “other acquisition or disposition.” Here, it reflects a restructuring-type event where 2,519 shares were issued privately to meet one-time obligations tied to a hospital transferred under a 2021 merger agreement.

Why did Nutex Health (NUTX) issue 2,519 shares to Kelvin Spears?

The 2,519 shares were issued to satisfy one-time obligations related to Spears’ pro-rata share of an under-construction hospital. That hospital had previously been transferred to Nutex Health Holdco LLC under a November 23, 2021 merger agreement referenced in prior proxy and Form 10-K filings.